Topic Listing for SERACARE LIFE SCIENCES

Acknowledgment Waiver Additional Contract Clauses
Additional Far Contract Clauses Included Full Text Additional Risk Factors
Additional Subsequent Events 2004 Adjustments Changes Stock
Adjustments Early Termination Administration
Administrative Agent Adopted 2007
Advance Understandings Advanced Understandings
Aggregate Maturities Aggregated Option Exercises Last Year-end Values
Agreement Agreement Shall Governed Construed Accordance Laws State New
Also Announces Key Additions Management Alternative Dispute Resolution
Amendment Consulting Agreement Amendment Employment Agreement
Amendment Solicitation Modification Contract Continuation Page Amendment Termination
Amendments Consulting Agreement Amendments Waivers
American Stock Transfer Trust Annexes Exhibits Riders Schedules
Annual Bonus Anti-takeover Defenses Place Prevent Frustrate Attempts Stockholders Change
Anti-takeover Effects Certain Charter Bylaw Provisions Asset Purchase Agreement
Assets Liabilities Transferred Contractual Arrangements Assignment Rotation Committee Members
Attached Attachment
Attendance Management Personnel Board Meetings Audit Committee
Audit Committee Compensation Audit Committee Report
Audit Fees Audit Non-audit Fees
Audit Related Fees Authorized Substitution Clauses
Available Information B-1
Bankruptcy Receivership Base Salary
Basis Presentation Bbi Acquisition
Bbi Diagnostics Biotech Segments Become Subject Foreign Restrictions Importation Blood Derivatives Result
Benchma Rking Compensation Benchmarking Compensation
Beneficial Ownership Reporting Compliance Biobanking
Biopharmaceutical Products Blood Test Mad Cow Disease
Bmr Acquisition Board Access Management
Board Committees Board Compensation
Board Compensation Committee Report Executive Board Composition
Board Director Compensation Board Directors Committees
Board Interaction Institutional Investors Analysts Press Customers Board Materials Distributed Advance
Board Meetings Participation Board Membership Criteria
Board Orientation Continuing Education Boards Goals
Bonus Awards Brief Description Supplies Services
Brown Brothers Harriman Union Bank California Revolving Term Business
Business Overview Business Significant Accounting Policies
Bylaws Call Additional Questions
Capital Credit Security Agreement Capital Leases
Cash Compensation Cash Equivalents
Cash Flows Cautionary Regarding Forward-looking Statements
Cautionary Statement Regarding Forward-looking Statements Celliance Acquisition
Certain Bankruptcy Matters Certain Business Relationships
Certain Claims Not Affected General Release Extend Certain Relationships Related Transactions
Certificate Service Certification
Certification Pursuant 1350 Chapter Title United States Code Change Vote
Changes Capital Structure Changes Demand Plasma-derived Products Availability Donated Plasma Affect
Changes Internal Control Chapter Bankruptcy
Chapter Bankruptcy Filing Chapter Reorganization
Charter Chief Executive Compensation
Claims Product Liability Errors Omissions Connection Services Perform Clauses Incorporated Reference Far 52252-2 1998
Closing Closing Balance Sheet Agreement
Code Ethics Code Ethics Chief Executive Senior Financial Officers
Code Ethics Conduct Corporate Governance Guidelines Collateral Administration
Collections Lockbox Account Commitments Contingencies
Committee Shall Deliver Board Report Oral Setting Forth Common Stock
Comparison 2006 2005 Comparison 2007 2006
Comparison Cumulative Total Return Compensation Committee
Compensation Committee Interlocks Insider Participation Compensation Committee Report
Compensation Directors Compensation Philosophy
Compensatory Arrangements Certain Officers Competition
Competitive Advantages Competitors
Compliance Code Ethics Compliance Environmental Requirements Hazardous Materials
Compliance Erisa Compliance Laws Anti-terrorism
Compliance Laws Rules Regulations Computation Earnings Loss Per Share
Concentration Credit Risk Conclusion
Conditions Conditions Each Loan Support Agreement Lender Letter Credit
Conditions Issuance Shares Conference Call Today 1100 Est
Confidentiality Information Conflicts Interest
Consent Spouse Consolidated Statement Changes Stockholders Equity
Consolidated Statement Operations Contact
Continuance Employment Required Commitment Contract Financial Report
Contract Research Contract Work Assignment
Contracting Officer Require Contractor Submit Detailed Support Costs Contractor Shall Never Send Out Last Vial Particular
Controls Panels Controls Procedures
Corporate Action Restriction Cost Compliance Failure Comply Sarbanes-oxley Act 2002 Adversely
Credit Facility Credit Security Agreement
Critical Accounting Policies Critical Accounting Policies Estimates
Ctl Analyzers Llc Current Report
Customers Customers Reduce Research Development Budgets Face Reduction Government
Debt Debtor Hoc Equity Committee Modified
Deferred Revenue Definitions
Deliveries Delivery Shares
Department Justice Department Justice Securities Exchange
Departure Directors Certain Officers Election Appointment Compensatory Departure Directors Principal Officers Election Appointment
Depend Contracts Government Agencies Terminated Reduced Material Adverse Deposit Accounts Securities
Derive Substantial Amount Revenue Limited Number Customers Description Awards
Designation Beneficiary Determination
Diagnostic Biopharmaceutical Products Director Attendance Annual Meetings Stockholders
Director Biographies Director Compensation
Director Independence Director Nominees Executive Officers
Director Nonqualified Stock Option Agreement Director Tenure
Directors Directors Change Present Job Responsibility
Disaster Facilities Substantially Impact Business Disclosure Controls Procedures
Disclosures Disposition Assets
Disposition Assets Subsequent Event Dividends
Domestic Corporation Domestic Foreign Sales
E-2 Early Termination Option
Earnings Per Share Election Director
Eligibility Elispot Kit Interferon Gamma Interleukin
Emergence Bankruptcy Employee Incentive Plans
Employee Stock Purchase Plan Employees
Employees Rights Employment Agreement
Employment Agreements Employment Arrangements
Employment Contracts Entire Agreement
Entry Material Definitive Agreement Environmental
Environmental Matters Epa Energy Star Requirements
Equity Awards Equity Committee Modified
Equity Compensation Plan Information Equity Security Ownership Management Other Beneficial
Estimate Estimated Cost Fixed Fee
Estimates Evaluation Executive Officers
Events Leading Chapter Filing Exact Name Registrant Specified Charter
Except Per Share Data Executive Compensation
Executive Compensation Components Executive Officers
Executive Officers Directors Exercise Option
Exhibits Expenses Indemnity Release
Face Additional Expenses Cash Funding Needs Pending Sale Face Additional Expenses Disruption Due Relocation Eventual Sale
Fail Attract Retain Qualified Scientific Production Personnel Lose Fail Maintain Adequate Quality Standards Products Services Business
Fail Realize Anticipated Strategic Operational Financial Benefits Recent Fail Timely Develop Introduce New Products Not Accepted
Failure Attract New Customers Obtain Additional Orders Existing Failure Comply Environmental Health Safety Laws Regulations Including
Failure Improve Product Offerings Develop Introduce New Products Failure Obtain Alternative Financing Fund Shortfall Created Potential
Failure Products Product Candidates Those Suppliers Customers Receive Failure Successfully Execute Acquisition Strategy Inhibit Growth
Fair Value Financial Instruments Federal Income Tax Consequences
Federal Income Tax Consequences Associated Stock Options Granted Federal Income Tax Consequences Espp
Fees Incurred Auditors Fees Independent Public Accountants
Fees Paid Auditors Other Kpmg Fin Accounting Uncertainty Income Taxes Interpretation Fasb Statement
Financial Condition Suffer Experience Unanticipated Costs Enforcement Action Financial Covenants
Financial Information Financial Reporting
Financial Reporting Processes Ceo Cfo Certifications Financial Statements Exhibits
Financing Cash Flows Find Information
Food Drug Administration Foreign Currency Exchange Risk
Foreign Restrictions Importation Exportation Blood Derivatives Form
Form 10-k Form Release Agreement
Former Name Address Changed Since Last Report Frederick Lease
Funds Interest Further Assurances
Gci Acquisition Gci Disposition
General General Information
General Provisions Regarding Payment Loan Account General Release Agreement
General Release Not Extend Claims Releasing Party Know Goodwill Intangible Assets
Goodwill Other Intangible Assets Governing Law Jurisdiction Agreement Shall Interpreted State California
Governing Law Limited Rights Government Property
Grant Option Grants Plan-based Awards
Gregory Gould Chief Financial Officer Gross Profit
Guarantees H10 Anti -lobbying
Hazardous Materials Remediation Hearing Scheduled
Heavily Rely Air Cargo Carriers Other Party Package Held 2005
Hhsar 352223-70 Safety Health 2001 History
Holders Human Materials Assurance Ohrp Compliance
Human Subjects Impairment Assets
Impairment Trade Name Important Notice Regarding Delivery Shareholder Documents
Inability Protect Intellectual Property Rights Prevent Selling Products Incentive Stock Option Agreement
Income Tax Benefit Expense Income Tax Expense
Income Tax Expense Benefit Income Taxes
Incur Increased Costs Compliance Risks Result Sarbanes-oxley Act Indemnification
Indemnification Agreement Indemnification Officers Directors
Indemnifications Independence Board
Independence Board Committees Independent Auditors
Independent Registered Public Accounting Firm Index
Index Defined Terms Index Exhibits
Index Financial Statements Indirect Cost Rates
Industries Market Segments Operate Highly Competitive Not Able Industry Overview
Inflation Inspection Acceptance
Intellectual Property Intellectual Property Other Litigation Alter Product Lines Very
Interest Calculations Certain Fees Interest Expense
Interest Expense Net Interest Expense Other Income
Interest Rate Market Risk Interruption Supply Diagnostic Therapeutic Products Competitive Prices Purchase
Interruption Supply Diagnostic Therapeutic Products Raw Materials Purchase Inventories
Investing Cash Flows Investment Common Stock Relatively Illiquid
Invoice Submission Contract Financing Request Involved Hazardous Materials Accident Unable Comply New Revised
Issue Preferred Stock Future Issue Preferred Stock Future Rights Senior Common
Issuer Purchases Equity Securities Katheryn Shea Vice President Bioservices Operations
Key Personnel Know Suspect Violation Applicable Laws Rules Regulations Code
Lack Dividend Payments Lack Early Success Pharmaceutical Biotechnology Customers Shut Out
Leases Legal Regulatory Compliance
Licensing Agreements Customer Claims Licensing Arrangements
Life Sciences Industry Highly Competitive Subject Rapid Profound Limited Manufacturing Capabilities Insufficient Produce Adequate Supply Products
Line Credit Liquidity Capital Resources
List Attachments Litigation
Loans Long-lived Assets
Long-lived Assets Deferred Costs Long-term Debt
Lose Material Portion Revenue Unable Transport Distribute Goods Loss Related Assets Held Sale
Maintenance Property Insurance Management Development
Management Incentive Program Manufacturing
Market Opportunities Marking
Material Modification Rights Security Holders Merger
Method Exercise Option Method Payment Contributions
Miscellaneous Name Person Filing Proxy Statement Other Registrant
National Cancer Institute Need Additional Capital
Need Additional Capital Not Available Economically Reasonable Terms Needle Exchange
Negative Covenants Net Income
Net Loss Continuing Operations Net Loss Per Share
Net Sales New Incentive Plan Benefits
Nominating Corporate Governance Committee Nominating Governance Committee
Nominees Re-election Directors Non-employee Director Compensation Arrangements
Non-transferability Other Restrictions Nonqualified Stock Option Agreement
Not Applicable Former Name Address Changed Since Last Notice 2008 Annual Meeting Stockholders
Notice 2009 Annual Meeting Stockholders Notice Sale
Notices Notices Litigation Defaults
Notification Number Names Board Committees
Occupational Safety Health Administration Occupational Safety Health Administration Osha
Off-balance Sheet Arrangements Offering Periods
Officers Operating Cash Flows
Operating Loss Operating Results Deteriorate Fail Maintain Proper Inventory Levels
Operations Option Agreement
Option Agreements Option Exercise Agreement
Option Grants Last Options
Options Exercised Stock Vested Other Actions Compensation Committee
Other Arrangements Directors Other Business
Other Compensation Other Contingencies
Other Events Other Fees
Other Matters Decided Annual Meeting Other Public Directorships
Outstanding Equity Awards Year-end Outstanding Equity Awards Year-end Option
Overview Packaging
Panels Controls Diagnostics Part
Part Other Information Participation
Pay-for-performance Philosophy Payment Sharing
Payments Claims Pays Cost Soliciting Proxies
Pbmc Control Performance Graph
Plan Plan Construction
Please Detach Along Perforated Line Mail Envelope Provided Policy Audit Committee Pre-approval Permissible Non-audit Services Independent
Possible Early Termination Plan Options Post Award Evaluation Contractor Performance
Potential Cut-back Potential Gross-up
Preferred Stock Press Releases
Primary Objectives Principal Business Segments
Principal Shareholders Exert Significant Influence Principles Consolidation
Privacy Act Privacy Law
Privileges Stock Ownership Pro Forma Adjustments Bbi
Pro Forma Adjustments Gci Pro Forma Consolidated Statement Operations
Procurement Certain Equipment Product Development
Product Liability Claims Material Adverse Effect Reputation Business Professional Corporation
Profits Likely Decline Unable Pass Price Increases Customers Project Officer
Properties Facilities Property Equipment
Proposal 1-election Directors Proposal 2-amendment 2001 Stock Incentive Plan
Proposal 3-aproval Employee Stock Purchase Plan Proposal Amendment Restatement Amended Restated
Proposal Approval 2009 Equity Incentive Plan Provisional Patent Application Stephen Warren Gregory Gould Kevin
Provisions Applicable Direct Costs Proxy Statement
Proxy Statement Accompanying Material Scheduled Sent Stockholders Publication Advertisement
Publication Publicity Purchase Commitments Suppliers
Purchase Price Adjustments Purpose
Quantitative Qualitative Disclosures Market Risk Quarterly Period 2004
Quarterly Period 2005 Quarterly Revenue Operating Results Fluctuate Future Periods Fail
Reagents Bioprocessing Products Real Property Mortgage
Recent Accounting Pronouncements Recent Accounting Standards
Recitals Recommendation Seracare Life Sciences Board Directors
Record Date Annual Meeting Reduced Demand Due Economic Downturn Overall Market
Registrants Business Operations Registrants Telephone Number 760 806-8922
Registrants Telephone Number Including Area Code Regulation Disclosure
Regulation Health Care Industry Regulation Laboratory Operations
Regulation Products Regulatory
Regulatory Environment Reimbursement Expenses
Related Party Relationships Transactions Related Party Transaction
Related Party Transaction Subsequent Event Relationship Among Primary Components Compensation
Relationship Independent Public Accountants Relocation Package
Rely International Sales Subject Additional Political Economic Risks Remainder Page Intentionally Been Left Blank
Remainder Page Intentionally Left Blank Reorganization
Report Independent Registered Public Accounting Firm Reporting Matters Involving Fraud Waste Abuse
Reporting Requirements Reporting Statistics
Reports Representations Buyer
Representations Certifications Representations Participant
Representations Warranties Representations Warranties Covenants Relating Collateral
Research Development Costs Research Development Expense
Research Development Expenses Reserved
Resignation Resignation General Release Agreement
Rest Page Intentionally Left Blank Signature Follows Results Operation Financial Condition
Results Operations Results Operations Financial Condition
Retirement Age Retirement Plan
Revenue Revenue Recognition
Review Approval Related Party Transactions Revolving Credit Facility Term Notes
Revolving Term Credit Security Agreement Rights Created
Rights Offering Risks Related Industry
Role Directors Ronald Dilling Vice President Manufacturing Operations
Royalty Commitments Safe Harbor Forward Looking Statements
Sale Assets Assumption Liabilities Sales Distribution
Sales Marketing Schedule A-1 Writing Applicable
Schedule I-b Securities Authorized Issuance Equity Compensation Plan
Securities Authorized Issuance Equity Compensation Plans Securities Exchange Act 1934
Securities Trading Markets Security Agreement
Segment Information Significant Customers Segment Reporting
Selected Quarterly Financial Data Amounts Except Per Share Selection Agenda Board Meetings
Selection Chairman Board Selection Executive Officers
Selection New Directors Self-evaluation Board
Selling General Administrative Expenses Separate Sessions Non-management Directors
Seracare Announces Completion Bankruptcy Reorganization Emergence Chapter Seracare Announces Entry Three-year Revolving Loan Facility
Seracare Announces Filing Chapter Petition Seracare Announces Internal Review Audit Committee
Seracare Announces Receipt Additional Notice Nasdaq Seracare Announces Receipt Delisting Notice Nasdaq
Seracare Announces Receipt Notice Nasdaq Seracare Life Sciences
Seracare Life Sciences Announces Closing Public Offering Common Seracare Life Sciences Announces Pricing Public Offering Common
Seracare Life Sciences Inc Seracare Names Cathryn Low Interim Chief Financial Officer
Seracare Names Mayer Hoffman Mccann Independent Auditor Seracare Provides Update Audit Committee Internal Review
Seracare Reiterates 2005 Guidance Service Commitment
Setting Assessment Performance Goals Severance Release Agreement
Sfas 141 Revised 2007 Business Combinations Sfas 157 Fair Value Measurements
Sfas 160 Noncontrolling Interests Consolidated Financial Statements Amendment Sfas 160noncontrolling Interests Consolidated Financial Statements Amendment Arb
Shareholder Communication Board Directors Shareholder Litigation
Shareholder Proposals 2006 Annual Meeting Shareholders Ability Sell Shares Stock Limited
Shareholders Purchase Rights Plan Shipping
Signature Signatures
Significant Reduction Government Regulation Drug Development Process Result Size Board
Soliciting Vote Solvency Each Borrower Additional Credit Party Solvent
Southern District California Specific Benefits
State Governments Statements Income
Stock Awards Options Stock Delisted Price Falls Below 100
Stock Option Agreement Stock Option Awards
Stock Option Plan Stock Options
Stock Performance Graph Stock Price Been Expected Continue Volatile
Stock Price Volatile Stock Subject Plan Share Limitations
Stock-based Compensation Stockholder Communications Board Directors
Stockholder Proposals Stockholders Equity
Stocks Traded Pink Sheets Subject Greater Market Risks Strategic Direction
Strategy Subject Facility Audits Customers Failure Comply Quality Control
Subject Governmental Reforms Adequacy Reimbursement Subject Risks Associated International Sales
Subject Significant Regulation Government Other Regulatory Authorities Subordinated Notes
Subsequent Event Subsequent Events
Substantial Amounts Common Stock Sold Near Future Succession Planning
Summary Amended Restated 2001 Stock Incentive Plan Summary Compensation Table
Summary Description Espp Supplemental Release Agreement
Suppliers Susan Vogt President Chief Executive Officer
Table Contents Tax Deductibility Compensation
Tax Fees Tax Withholding
Taxes Capital Adequacy Tender Offer
Term Plan Amendment Termination Termination
Termination Employment Change Eligible Status Termination Material Definitive Agreement
Termination-based Compensation Terms Debt Covenants Limit Conduct Business Ability Raise
Top Form Transactions Management Others
Transferability Treatment Executory Contracts Unexpired Leases
Ucc Remedies Unable Protect Trade Secrets Know-how Trademarks Other Intellectual
Unable Realize Growth Strategy Cannot Identify Suitable Acquisition Unregistered Sales Equity Securities
Unregistered Sales Equity Securities Proceeds Vesting Limits Exercise
Vote Vote Required
Votes Cast Stockholders Waivers
Waivers Code Ethics What Boards Recommendations Vote Shares
What Happens Meeting Postponed Adjourned What Mean Receive Proxy Card Voting Instruction Form
What Quorum Vote Required Approve Each William Smutny Vice President Sales Marketing
Witnesseth Work Assignment Procedures
Write Above Xvi Recent Accounting Pronouncements
Xvi Stock-based Compensation Xvii Stock-based Compensation
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki